Looking for the next big boom
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think it was in the neighborhood of 23 mil, Board correct me if I am wrong. Go back and read all the posts on 10/22. People paniced, I (as well as others) used it as an opportunity to double and triple our position.
Powerbattle took a very strong opposition to the CEO releasing a large amount of shares last week and left. I think Blanka may have left as well.
$IGEX trying to make a move. .0006
And Second, NOTHING moves on a saturday..LOL
Well first ORPH is still in the pinks and ALXN is trading on the NASDAQ at $171 a share. AVXL is officially on the Nasdaq as of opening bell tomorrow and releasing data first part of November for a treatment that is potentially 100's of percentace better than current treatment to date. To say that this is going to remain a $10 stock when the real players on the big board notice and do their DD is asinine. If that does not "enlighten"...nothing will.
getting close to the first mil shares. It stays this low for a little while longer and 2 mil will be easy.
I feel as though that is the case, just this .0004 thing is scary. I have been holding and accumulating for a long time, in too deep to walk away now. FIngers crossed, seems as though to much has been invested for this company to fail this early.
Not feeling real strong about this mornings start? Looking for a bounce today, but the ball may be out of air
Great news today. Brace yourselves for all the basher backpedaling and "thats not what I said.." Posts to start filling the board before they slink away back into the dark.
They will come, It just broke at closing bell, as ppl discover this info over the weekend you will see alot of hooplah. Monday shall be a VERY interesting day indeed.
Filing Date
2015-10-23
Accepted
2015-10-23 15:17:38
Documents
1
Filing Date Changed
2015-10-23
Effectiveness Date
2015-10-23
Just took advantage of the 6s. Time to hold. If it ticks up again, will buy more. GLTA
If you cannot get through the info@igex.com address, ask John directly.
Email given via IGEX.com: john.oshea@igex.com
I was able to get an email through (Or at least the system confirmed it was delivered) to info@igex.com. I sent a simple inquiry and do not expect a response, but will update the board if something comes back.
My email:
"As I am sure I am one of many making an inquiry, I anticipate a slowed response and accept that. Obviously today the stock price per share took a major hit due to what looked like 20+ million shares being released, possible dilution. This has undoubtedly created quite a panic among investors. Is there any legal information that can be shared or relayed to help comfort the shareholders and clean up the perception cast on todays events?
Thank you for your time and response,"
I am hoping the web portal email is just down do to massive traffic from people inquiring as to what the hell happened today. Time will tell. This is either gonna bounce with a vengance or no bid. Either way I do not believe we will have long to wait for the answer.
and all the negative panic helps? creating a panic selloff and doomsday prophecies are rectifying the situation. Anyone that has spent any time below the OTC/Pinks understands Risk etc. This may not come back, but there currently is too much on the table to believe this has been a cardboard store front. It dropped 50% and it was like turning the lights on and watching roaches scatter. I counter the panic with some common sense. I do know gaurantee this will bounce back, but I am not ready to scream "The sky is falling"
I sent John an "InMail" on his Linkdin account looking for clarity on what is the meaning behind the dump. Nothing back so far.
https://au.linkedin.com/pub/john-o-shea/62/9a3/64b
Growth opportunities can be an indicator of a potential share dilution. Secondary offerings are commonly used to obtain investment capital that may be needed to fund large projects and new ventures.
Stock dilution, however, isn't always bad. But before we look at when it can be good, let's consider the iffy situation of a company that acquires another one and pays for the purchase in stock. Say Phaser wants to expand its business but it hasn't gotten its gun to work just yet. That poses a problem. As the solution, Phaser decides to buy out a rival, defense contractor General Dynamics (NYSE:GD). Since Phaser hasn't sold anything and doesn't have any actual, er, cash, it wants to issue its own stock to General D shareholders in exchange for their shares.
Now, General D has a market cap of roughly $20 billion. With Phaser shares trading for $10 a stub, our intrepid Trekkie will have to issue 2 billion new shares to acquire its heart's desire. Doing that will dilute Joe, and Phaser's other shareholders, by 200,000 times. In what universe could that much dilution possibly be a good deal for Phaser shareholders?
The answer requires another question: Is Phaser overpaying for its purchase? If Phaser pays a price equal to General D's intrinsic value as a business, then the dilution created by the purchase does not really hurt Joe. Yes, Joe's slice of the merged Phaser/General D pie looks much smaller than his slice of Phaser alone does. But the new pie is much bigger. Picture this: Joe's receiving a much thinner but also much longer slice of Phaser/General D pie, in return for his original wide but stubby slice of Phaser.
all this does is make it waaay easier for me to get to my goal of a million shares and then just sit and wait. Too much going on here for Igex to not recover, just gonna take longer as we wade through the dilution. True longs and I mean TRUE longs arent even watching because they know the day to day of the OTC will drive you mad. If you are in the red right now with this, stop following this board and this stock for about 8 weeks, then come back.
wow all the promise this company has shown and everyone turns soft basher after a tumble. Day to day pps is irrelevant. You get out now and I can, In my own opion, say this time next year you will be very very dissapointed in yourself. Why would a company go through this much to aquire the caliber of partners it has and for that matter why would partners of that caliber get in bed with this company if success was not planned on or on the horizon. You really think all this was put together just to dump shares and run? If you are feeling like a weak hand, then move on cause I am sticking to my guns and buying low.
yep! I picked up a small 41k yesterday on some pocket change, once pay day hits I grabbing another 250k minimum on my quest to a million shares!!! GLTY and GLTA
I need this to stay in the trips for one more day so I can grab another few hundred thousand shares on payday lol. Once revenue info leaks out, this will no longer be a subpenny stock. Ameritrade traded for .97 cents at one time, now its a $30+ stock, IGEX has everything it needs to be just as heavy a hitter. Its first in market, amazing roster and years ahead of any direct regional competitor. It has the indo/asia/eruo market cornered for years. spend $100, get 100,000 shares, Join the new millionaires club when it hits $10! $IGEX$
agreed! I am filling truckload after truckload at these prices. If this company performs HALF as well as lets say Ameritrade, this is a $15 pps stock. Who else wants to stand in the "New millionare 2016 club" line with me? there is gonna be a celebration party and BBQ at the end
Sure glad all these fully recognized and reputable finacial institutions and big players with lots to loose are in on the sham to make it more believable......HAHA what a joke. every message board has a couple of "these guys" Chicken little's always screaming the sky is falling. They all use the same lines. "Gagged TA/Dilution/Split/Scam or sham" browse a handfull of boards or click on their posts list, you will see a tremendous pattern and ALOT of repeat fear mongering. If the company they are "saving us from" was as a bad investment as they would like you to believe, they would not be here, they would be where the money is, shaking those trees. Do your OWN DD and never listen to "Doom and gloom" and for that matter never listen to "Way over the top" nonsense as well. Find the facts and the finacials etc. Make a decision, invest what you can lose and ignore the noise.
Keep eyes open, any day now
http://otce.finra.org/DLSymbolNameChanges
Keep eyes open, any day now
http://otce.finra.org/DLSymbolNameChanges
IGEX is having a SALE!!! load up while its cheap, This time next year you will wish you did. Etrade/Ameritrade of the Indo/asia/and now australian/european markets. Connect the dots, do your DD, ignore the "noise" from those that wish to mislead. Scared to invest? $100 will get you 100k shares at these prices. This could be a $30 stock in 4-5 years, maybe less. DO THE MATH? if it tanks....you lost $100 (price of a nice dinner for two), If it succeeds and matches pps of similar companies.. MILLIONS of $100. I AM ALL IN ON MY WAY TO 500K SHARES, hoping to get to a mil shares before end of year. All imho, GLTA
Will we see some quick profit taking this morning and a late afternoon blue sky run or steady upward trend over course of day?
1.5 Mil Volume 9 minutes in!!!!!! gonna be a good day tater!!
Elite Pharmaceuticals Sees Filing NDA to FDA for Abuse-Deterrent ELI-200 By Yr End>ELTP
DJ Realtime News - 8:01 am ET 10/21/2015
Elite Pharmaceuticals Says Pivotal Trial Met Its Primary Endpoint
DJ Realtime News - 8:00 am ET 10/21/2015
Elite Pharmaceuticals Announces Positive Top-Line Results From a Pivotal Phase 3 Study for Abuse-Deterrent Opioid ELI-200
October 21, 2015: 08:00 AM ET
NORTHVALE, N.J., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced positive top-line results from the Phase 3 pivotal trial of its lead opioid abuse-deterrent candidate, ELI-200, for the treatment of moderate to severe pain.
The pivotal trial met its primary endpoint (p = 0.001), demonstrating statistical significance that the product provided pain relief following surgery in the treatment group using ELI-200 compared to the placebo group. Secondary endpoint results were consistent with primary findings and included safety measures. There were no serious adverse events or deaths related to ELI-200 reported during the conduct of the trial.
Elite intends to submit a New Drug Application to the U.S. Food and Drug Administration for abuse-deterrent ELI-200 by year-end.
"I am pleased with completing this important step in the commercialization of our first abuse-deterrent product, ELI-200," said Nasrat Hakim, President and Chief Executive Officer of Elite. "The next significant step will be the submission of the NDA for ELI-200 which I expect to occur by year-end.”
About the Phase 3 ELI-200 Trial
The Phase 3 study evaluated safety and efficacy following dosing of ELI-200 for the treatment of moderate to severe pain following surgery. It was a multicenter, randomized, multiple-dose, double blind, placebo-controlled, and parallel group study. The clinical trial was conducted at five study sites in the United States which randomized 163 patients into the clinical study.
About Elite’s Abuse Deterrent Technology
Elite’s proprietary abuse deterrent technology, ART™, is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases as intended providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed or dissolved, the opioid antagonist is designed to release and so block the effects of active opioid agonist. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to the same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers. Elite’s pharmacological approach to abuse-deterrence can be applied to a wide range of opioids used today in pain management.
About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma and Valeant Pharmaceuticals International. Elite currently has eight commercial products being sold, additional approved products pending manufacturing site transfer and a product under review pending approval by the FDA. Elite’s lead pipeline products include abuse-deterrent opioids which utilize the Company’s patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.), and a Hong Kong based company for development of a branded product for the United States market and its territories. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Including those related to the effects, if any, on future results, performance or other expectations that may have some correlation to the subject matter of this press release, readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, its ability to obtain FDA approval of the transfers of the ANDAs or the timing of such approval process, delays, uncertainties, inability to obtain necessary ingredients and other factors not under the control of Elite, which may cause actual results, performance or achievements of Elite to be materially different from the results, performance or other expectations that may be implied by these forward-looking statements. These risks and other factors, including, without limitation, the Company’s ability to obtain sufficient funding under the LPC Agreement or from other sources, the timing or results of pending and future clinical trials, regulatory reviews and approvals by the Food and Drug Administration and other regulatory authorities, intellectual property protections and defenses, and the Company’s ability to operate as a going concern, are discussed in Elite's filings with the Securities and Exchange Commission, including its reports on forms 10-K, 10-Q and 8-K. Elite undertakes no obligation to update any forward-looking statements.
Contact:
Elite Pharmaceuticals, Inc.
Dianne Will, Investor Relations
518-398-6222
Dianne@elitepharma.com
http://money.cnn.com/news/newsfeeds/articles/globenewswire/6010209.htm
This is a "Golden Egg" stock, why would ANYONE sell here!!?? This thing has to hit $20 before I even start to consider selling any shares. WAY to much potential here. This is an early retirement stock!!
Has anyone heard anymore on when we may see the Ticker change? still being branded a mattress company is killing us.
IGEX Expands Leading Global Trading Platform in Partnership with TandemFx and Yellow Octopus to target Australia.
IGEX Expands Leading Global Trading Platform in Partnership with TandemFx and Yellow Octopus to target Australia.
JAKARTA, INDONESIA -- October 20, 2015 -- InvestorsHub NewsWire -- Indo Global Exchange Pte., LTD (the "Company") (OTC Pink: IGEX), a growing provider of online global markets and trading platforms to securities and commodities investors today announced it has established a strategic partnership with TandemFx and Yellow Octopus to operate in Australia. Following IGEXs rapid expansion throughout the Asian and Pacific Rim markets, the partnership with TandemFx and Yellow Octopus, will assist in bringing a unique distribution capability and trading platform to investors in Australia.
Yellow Octopus signed an amendment to the IGEX agreement allowing Yellow Octopus the rights to promote and distribute IGEX products within Australia under the TandemFx Brand which operates under ASIC guidelines.
TandemFX is owned and operated by Richard Jackson of Jackson Capital based in Melbourne and is the developer of the strategies IGEX uses.
Richard Jackson said "Yellow Octopus approached TandemFX and IGEX to expand its offering outside of Singapore, Honk Kong and China allowing Yellow Octopus to promote in Australia. Although TandemFX operates and promotes its own services in Australia, it is our belief that there is a big enough market to have a number of players promoting the services. Yellow Octopus have an established network which is a great advantage to TandemFX. Introductions to a number of substantial players have already taken place and all parties will gain from this extensive network."
Kit Foo Chy, Director of Yellow Octopus, said they "have received a number of requests from financial planners, and other funds managers within Australia, to gain access to IGEX services. This is a huge opportunity for all parties and we are very happy to be working closely with IGEX and TandemFx to offer their services to our network in Australia utilizing their financial services license under ASIC to promote the product."
John O'Shea said "Yellow Octopus have started promoting the IGEX products and we have on boarded many clients that are funding their accounts. This is bringing trading revenues to IGEX never seen before. There has also been negotiations that the target of $6,000,000 of new funds under management by Yellow Octopus is brought forward to April 2016. This means that any bonus payments will stop after this date, so Yellow Octopus must work extra hard to get new clients before this deadline to achieve maximum return."
About IGEX
Indo Global Exchange (IGEX) is at the forefront of the emerging financial markets service sector, partnering with noteworthy licensed suppliers of sophisticated global trading platforms in Equities, CFDs, Derivatives, Commodities, Energies, Foreign Exchange and Options. IGEX's local knowledge coupled with world class partners gives clients security and 100% transparency, which is critical for entry into this large and relatively untapped Pacific Rim marketplace.
For more information about IGEX's business, mission and strategic partners, visit: www.igex.com.
For more information about TandemFx, please visit: http://www.tandemfx.com.au/
Notice Regarding Forward-Looking Statements
This news release contains forward-looking statements, which reflect our views with respect to future events and financial performance. These forward-looking statements are subject to certain uncertainties and other factors that could cause actual results to differ materially from such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.
There is no "gagged TA" or "Pre-authorized split" nice try, wont miss you in the slightest. cheers
I think I am done following George's bread crumb trail. It just seems to go in circles and has no deffinitive destination. the PRs all seem to say the same thing over the years with different "Company Names" tied to them. I pray that I am wrong and this just needs more time as the technology could be astonishing if perfected. At this point in time I accept the fact that I am holding the bag and am done following the boards on this one. I will check back in on this in 6 months and see if anything has changed. GLTA and hope for big things.
For awhile I worried I was way late to the party when I bought in at $.80. Not feeling so bad these days! Post R/S I am feeling real good about my choice to jump in when I did. GLTA!!
Uplisting to NASDAQ, positive data history so far, confirmation of data presentation date, interest and exposure building exponetially, strong affirmation with MJFF support and you think we are to believe this is going to crash? Common sense ALONE should tell you this is a solid move and do not let 1 single bottom feeder on this board talk you out of your position. Only positive things have transpired to date, why would you get off the ride before its over? this thing has $$$$$ written up and down and all over every freakin side. GLTA!!!